文献速递创伤与烧伤重症综合管理与镇静镇痛

侵袭性创伤中的生命威胁:受伤患者创伤后应激障碍的关键风险因素

Life threat during assaultive trauma: Critical posttraumatic stress disorder risk factors for injured patients.
PubMed 文献 · J Trauma Acute Care Surg · 2022-01-25
一句话结论侵袭性创伤且围创伤期感到生命威胁的伤员,1个月和6个月时侵入性症状持续升高、6个月时回避症状增加,是PTSD的高危人群。

本研究纳入一级创伤中心收治的成年创伤幸存者,住院期间评估围创伤期感知生命威胁并按损伤机制分为侵袭性与非侵袭性创伤,伤后1个月(N=137)和6个月(N=220)用临床医生用PTSD量表(DSM-5)评估。结果显示生命威胁、创伤类型与时间的交互作用对侵入性症状和回避症状显著:侵袭性创伤合并生命威胁者侵入性症状持续升高、6个月时回避增加;而仅有生命威胁或仅有侵袭性创伤者6个月时症状减轻。作者认为该组合人群是伤后PTSD的特定高危群体,住院期间应评估这些围创伤期因素,并支持针对回避和侵入性症状的早期干预。

要点

  • 侵袭性创伤且围创伤期感到生命威胁的伤员,侵入性症状在1个月至6个月持续升高,回避症状在6个月时增加。
  • 仅有生命威胁或仅有侵袭性创伤的伤员,6个月时PTSD症状反而减轻。
  • 生命威胁、创伤类型与时间对侵入性症状和回避症状存在显著交互作用。
  • 作者认为住院期间应评估围创伤期生命威胁与损伤机制,以识别PTSD高危伤员。
  • 作者支持对该高危组早期干预,靶向回避与侵入性症状。

适用人群与场景

  • 收治于一级创伤中心的成年创伤幸存者。
  • 住院期间评估围创伤期感知生命威胁,损伤机制分为侵袭性与非侵袭性两类。

诊断标准与关键阈值

  • 采用临床医生用PTSD量表(DSM-5版)在伤后1个月(N=137)和6个月(N=220)评估PTSD症状。
  • 评估PTSD四个症状簇:侵入性症状、回避、高唤醒、负性情绪/认知。

红旗征与不能漏的情况

  • 侵袭性创伤且围创伤期感到生命威胁者,侵入性症状持续升高、6个月时回避增加,属PTSD高危群体。
  • 回避可延长功能损害并阻碍获得医疗照护,对康复产生负面影响。

研究设计与关键结果

  • 研究为一级创伤中心成年创伤幸存者的预后/流行病学研究,住院期间评估感知生命威胁并记录损伤机制。
  • 采用四个2(时间)×2(生命威胁)×2(创伤类型)混合设计方差分析检验四个PTSD症状簇。
  • 生命威胁、创伤类型与时间对侵入性症状和回避症状存在显著交互作用。
  • 侵袭性创伤合并生命威胁者侵入性症状跨时间持续升高,6个月时回避增加。
  • 仅有生命威胁或仅有侵袭性创伤者6个月时症状减轻。

证据类型、等级与局限

  • 证据类型:预后/流行病学研究,证据等级Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为住院期间应评估围创伤期生命威胁与损伤机制,以识别PTSD高危伤员。
  • 作者支持对该高危组早期干预,靶向回避和侵入性症状。
  • 回避可延长功能损害并阻碍获得医疗照护,对康复产生负面影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Rates of posttraumatic stress disorder (PTSD) among injury survivors are higher relative to the general population, supporting the need to identify those most at risk for PTSD following injury given negative impact of PTSD on recovery. Perceived life threat and assaultive trauma are consistent risk factors for subsequent PTSD development, although less work has explored them in combination. The current study evaluated whether trauma type (assaultive vs. nonassaultive) and perceived life threat, together, led to greater PTSD symptoms 1 month and 6 months postinjury.

METHODS: Participants included adult injured trauma survivors admitted to a level 1 trauma center. While hospitalized, perceived life threat during trauma was assessed and mechanism of injury was collected via record review and was collapsed into two categories: assaultive and nonassaultive. The Clinician-Administered PTSD Scale (Diagnostic and Statistical Manual of Mental Disorders [Fifth Edition]) was administered at 1 month (N = 137) and 6 months (N = 220) after injury.

RESULTS: The four symptoms clusters of PTSD (intrusions, avoidance, hyperarousal, and negative mood/cognitions) were examined using four 2 (time) × 2 (life threat) × 2 (trauma type) mixed methods analyses of variance to assess differences based on risk factors and time. Results showed significant interaction effects of life threat, trauma type, and time for intrusive symptoms and avoidance symptoms. Individuals with life threat during assaultive traumas maintained heightened intrusive symptoms across time and increased avoidance at 6 months. On the other hand, participants with either life threat or assaultive traumas had decreased symptoms at 6 months.

CONCLUSION: Experiencing assaultive trauma and life threat led to greater symptoms of PTSD. Individuals with assaultive traumas who experienced life threat may represent a specific at-risk group following injury. Avoidance can protract functional impairment and impede access to care, negatively impacting recovery. This study highlights a need to assess for these peritrauma factors during hospitalization and supports early intervention targeting avoidance and intrusive symptoms in this group.

LEVEL OF EVIDENCE: Prognostic/Epidemiologic, Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Timmer-Murillo SC, Schramm A, deRoon-Cassini TA, et al. Life threat during assaultive trauma: Critical posttraumatic stress disorder risk factors for injured patients. J Trauma Acute Care Surg. 2022. PMID: 35468115. doi:10.1097/TA.0000000000003543

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。